Form 4: Thermo Fisher Scientific Director Increases Stake Through Deferred Compensation Plan
Insider Transaction Report
R. Alexandra Keith, a Director at Thermo Fisher Scientific Inc., acquired 76.54 phantom stock units through the company's Deferred Compensation Plan for Directors.
Summary
- R. Alexandra Keith, a Director of Thermo Fisher Scientific Inc. (TMO), acquired 76.54 phantom stock units.
- The acquisition occurred on June 28, 2025, as part of the Issuer's Deferred Compensation Plan for Directors.
- These phantom stock units were credited to the Director's account at a price of $408.28 per unit.
- Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock at quarter end.
- The phantom stock units are convertible into Common Stock on a 1-for-1 basis.
- Following this transaction, R. Alexandra Keith beneficially owns 1,083.18 derivative securities (phantom stock units).
- The shares are distributable as stock upon cessation of director service for any reason or a change of control.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive as it indicates a director's continued accumulation of company equity through a compensation plan, aligning their interests with shareholders. It is a routine transaction, not indicative of major news.
Positives
- The acquisition of phantom stock units by a director aligns their interests with those of shareholders, as their compensation is tied to the company's stock performance.
- Participation in the Deferred Compensation Plan for Directors indicates a structured approach to executive compensation and retention.
Future Outlook
Phantom stock units are distributable as common stock upon the cessation of director service (for any reason) or a change of control of the company.
Industry Context
NA
Stakeholder Impact
- Shareholders: The transaction demonstrates continued alignment of director interests with shareholders through equity-based compensation.
Key Dates
| Date | Description |
|---|---|
| 06/28/2025 | Date phantom stock units were credited to the Reporting Person's account. |
| 07/01/2025 | Date the Form 4 was signed by the Attorney-in-Fact for R. Alexandra Keith. |
Keywords
Thermo Fisher Scientific, TMO, SEC Form 4, Insider Transaction, Phantom Stock Units, Deferred Compensation Plan, Director Compensation, Equity Compensation, Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.